Results 151 to 160 of about 17,990 (247)

Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis. [PDF]

Dis Markers, 2012
Ramírez-De los Santos S, Sánchez-Hernández PE, Sánchez-Hernández PE, Muñoz-Valle JF, Palafox-Sánchez CA, Rosales-Rivera LY, García-Iglesias T, Daneri-Navarro A, Ramírez-Dueñas MG.   +8 more
europepmc   +1 more source

Exposure to Occupational Inhalants and the Risk of Developing Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

Arthritis &Rheumatology, EarlyView.
Objective Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint pain, swelling, and stiffness. Although smoking is a well‐established risk factor for RA, the role of occupational inhalants in RA development is less well recognized.
Qianwen Liu, Xin Song, Emily Mauro, Yuan Jiang, Klementy Shchetynsky, Lars Klareskog, Lars Alfredsson, Xia Jiang   +7 more
wiley   +1 more source

Functionalized Imidazolium Ether-Free Polymer Backbones with Ion Transport Channels and Catalytic Activity

ACS Materials Au
Bryan A. Corzo, Hugo Hernández-Martínez, Eugenia Josefina Aldeco-Pérez, Jorge Cárdenas, Víctor Lara, Lilian I. Olvera   +5 more
doaj   +1 more source

Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis. [PDF]

Dis Markers, 2009
Ortiz GG, Macías-Islas MA, Pacheco-Moisés FP, Cruz-Ramos JA, Sustersik S, Barba EA, Aguayo A.   +6 more
europepmc   +1 more source

Los Secretos de la Redada de los 41 (The Secrets of the Raid of the 41): A Sociohistorical Analysis of a Gay Signifier [PDF]

, 2018
Espinoza, Lucas E, Resendiz, Rosalva
core   +1 more source

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring

Arthritis &Rheumatology, EarlyView.
Objective Using a hydroxychloroquine (HCQ) dose of 5 mg/kg/day in systemic lupus erythematosus (SLE) is associated with a higher risk of flares; HCQ blood level monitoring could be a better way to adjust the HCQ dose. We studied the upper threshold for a reference range of HCQ levels to inform routine monitoring.
Shivani Garg, Benoît Blanchet, Yann Nguyen, Fauzia Hollnagel, Ada Clarke, Michelle Petri, Murray B. Urowitz, John G. Hanly, Caroline Gordon, Sang‐Cheol Bae, Juanita Romero‐Diaz, Jorge Sanchez‐Guerrero, Ann E. Clarke, Sasha Bernatsky, Daniel J. Wallace, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N. Bruce, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey‐Goldman, Susan Manzi, Andreas Jönsen, Graciela S. Alarcón, Ronald F. Van Vollenhoven, Cynthia Aranow, Véronique Le Guern, Meggan Mackay, Guillermo Ruiz‐Irastorza, S. Sam Lim, Murat Inanc, Kenneth C. Kalunian, Søren Jacobsen, Christine A. Peschken, Diane L. Kamen, Anca Askanase, Jill Buyon, Julie Chezel, Alicja Puszkiel, Nathalie Costedoat‐Chalumeau   +42 more
wiley   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

Arthritis &Rheumatology, EarlyView.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, for the TULIP‐SC investigators   +12 more
wiley   +1 more source

Antimycobacterial Precatorin A Flavonoid Displays Antibiofilm Activity against Mycobacterium bovis BCG

ACS Omega, 2023
Esmeralda Ivonne Niño-Padilla, Clara Espitia, Carlos Velazquez, Efrain Alday, Erika Silva-Campa, Alexel Burgara-Estrella, José Antonio Enciso-Moreno, Olivia Valenzuela, Humberto Astiazarán-García, Adriana Garibay-Escobar   +9 more
doaj   +1 more source